Notably, wogonoside administration decreased the human CD45+-positive leukocytes in peripheral blood of mice (Figure 5b), suggesting that wogonoside reduced the number of leukemia cells in AML-bearing NOD/SCID mice. This evidence concerns the gene PTPRC and acute myeloid leukemia.